These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7240965)

  • 1. Molecular species of biliary phosphatidylcholines in gallstone patients: the influence of treatment with cholic acid and chenodeoxycholic acid.
    Ahlberg J; Curstedt T; Einarsson K; Sjövall J
    J Lipid Res; 1981 Mar; 22(3):404-9. PubMed ID: 7240965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment.
    Ahlberg J; Angelin B; Einarsson K
    J Lipid Res; 1981 Mar; 22(3):410-22. PubMed ID: 7240966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portal venous bile acids in cholesterol gallstone disease: effect of treatment with chenodeoxycholic and cholic acids.
    Einarsson K; Ahlberg J; Angelin B; Björkhem I; Ewerth S
    Hepatology; 1985; 5(4):661-5. PubMed ID: 4018738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chenotherapy for gallstone dissolution. II. Induced changes in bile composition and gallstone response.
    Hofmann AF; Thistle JL; Klein PD; Szczepanik PA; Yu PY
    JAMA; 1978 Mar; 239(12):1138-44. PubMed ID: 628065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The goose that laid the golden bile: gallstone dissolution in man with chenodeoxycholic acid.
    Dowling RH
    Ir J Med Sci; 1974 Jul; 0(0):suppl:115-27. PubMed ID: 4212419
    [No Abstract]   [Full Text] [Related]  

  • 6. The biochemistry of gallstone formation.
    Bouchier IA
    Clin Gastroenterol; 1973 Jan; 2(1):49-66. PubMed ID: 4271976
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of varying doses of chenodeoxycholic acid on bile lipid and biliary bile acid composition in gallstone patients: a dose-response study.
    Thistle JL; Hofmann AF; Yu PY; Ott B
    Am J Dig Dis; 1977 Jan; 22(1):1-6. PubMed ID: 835542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallstone dissolution in man using cholic acid and lecithin.
    Toouli J; Jablonski P; Watts JM
    Lancet; 1975 Dec; 2(7945):1124-6. PubMed ID: 53604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometry identification of biliary bile acids in bile from patients with gallstones before and during treatment with chenodeoxycholic acid. An ancillary study of the National Cooperative Gallstone Study.
    Stellaard F; Klein PD; Hofmann AF; Lachin JM
    J Lab Clin Med; 1985 Apr; 105(4):504-13. PubMed ID: 3981060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithocholate metabolism during chenotherapy for gallstone dissolution. 1. Serum levels of sulphated and unsulphated lithocholates.
    Allan RN; Thistle JL; Hofmann AF; Carter JA; Yu PY
    Gut; 1976 Jun; 17(6):405-12. PubMed ID: 955495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of cholesterol between vesicles and micelles in human gallbladder bile: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid.
    Sahlin S; Thyberg P; Ahlberg J; Angelin B; Einarsson K
    Hepatology; 1991 Jan; 13(1):104-10. PubMed ID: 1988332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ursodeoxycholic acid administration on biliary lipid composition and bile acid kinetics in cholesterol gallstone patients.
    Roda E; Roda A; Sama C; Festi D; Mazzella G; Aldini R; Barbara L
    Dig Dis Sci; 1979 Feb; 24(2):123-8. PubMed ID: 428300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissolution kinetics of cholesterol in simulated bile II: influence of simulated bile composition.
    Kwan KH; Higuchi WI; Hofmann AF
    J Pharm Sci; 1978 Dec; 67(12):1711-4. PubMed ID: 722485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bile acid feeding on cholesterol metabolism in gallstone patients.
    Hoffman NE; Hofmann AF; Thistle JL
    Mayo Clin Proc; 1974 Apr; 49(4):236-9. PubMed ID: 4817832
    [No Abstract]   [Full Text] [Related]  

  • 16. Biliary lipid output and bile acid kinetics in cholesterol gallstone disease. Evidence for an increased hepatic secretion of cholesterol in Swedish patients.
    Nilsell K; Angelin B; Liljeqvist L; Einarsson K
    Gastroenterology; 1985 Aug; 89(2):287-93. PubMed ID: 4007420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Criteria for selection of patients for medical treatment (chenodeoxycholic acid therapy) of gallstones.
    Bruusgaard A; Malver E; Pedersen LR; Schlichting P; Sylvest J
    Scand J Gastroenterol; 1977; 12(1):97-102. PubMed ID: 834976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 7-Methyl bile acids: effects of chenodeoxycholic acid, cholic acid, and their 7 beta-methyl analogues on the formation of cholesterol gallstones in the prairie dog.
    Matoba N; Cohen BI; Mosbach EH; Stenger RJ; Kuroki S; Une M; McSherry CK
    Gastroenterology; 1989 Jan; 96(1):178-85. PubMed ID: 2909419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased formation of ursodeoxycholic acid in patients treated with chenodeoxycholic acid.
    Salen G; Tint GS; Eliav B; Deering N; Mosbach EH
    J Clin Invest; 1974 Feb; 53(2):612-21. PubMed ID: 11344576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of gallbladder in gallstone formation.
    Nakayama F; van der Linden W
    Acta Chir Scand; 1974; 140(1):45-9. PubMed ID: 4819022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.